Wood Blewit

Metadata

Regulatory Status

European Union

• Status: Widely consumed as a traditional edible mushroom across Europe. Available commercially in markets and supermarkets in France, Spain, Portugal, and other EU countries during autumn and winter. Some limited commercial cultivation exists.
• Novel food status: Not subject to novel food regulation as a traditional food with well-documented history of consumption in the EU.
• EMA/HMPC: No monograph or assessment report.
• Traditional use: Long history of foraging in temperate woodlands across Europe. Particularly popular in French, Spanish, and Portuguese cuisine. Traditionally prepared sauteed, in stews, or preserved by drying.

United Kingdom

• Status: Known wild edible mushroom. Widely foraged in autumn and early winter in deciduous and mixed woodlands.
• Traditional use: Historical foraging tradition; the common name “blewit” derives from “blue hat,” referring to the lilac-blue coloration.

United States

• FDA GRAS status: No GRAS determination.
• Dietary supplement: Not marketed as a dietary supplement.
• Wild harvesting: Found across North America; known to foragers in temperate regions.

China and East Asia

• Status: Distributed across temperate Asia. Not a major commercial or medicinal mushroom in Chinese or Japanese traditions. Some research on the species has been conducted by Chinese and Taiwanese research groups.
• Chinese Pharmacopoeia / Japanese Pharmacopoeia: Not listed.

Australia

• Status: Present in Australian temperate forests. Used by foragers with appropriate knowledge.

Conditions & Indications

Primary: Immune Modulation via Dendritic Cell Activation (Preclinical Evidence Only)

• Dendritic cell maturation: Water extract of C. nuda (WE-CN) induces phenotypic and functional maturation of murine bone marrow-derived dendritic cells (BMDCs). WE-CN increases expression of MHC class II molecules, costimulatory molecules (CD40, CD80, CD86), and maturation markers on dendritic cell surfaces. Functionally, WE-CN-treated dendritic cells enhance allogenic T cell proliferation and IFN-gamma secretion, indicating promotion of a Th1 immune response.
• DNA vaccine adjuvant potential: Co-administration of WE-CN with a HER-2/neu DNA vaccine induced a HER-2/neu-specific Th1 response in mice, resulting in significant inhibition of HER-2/neu-overexpressing MBT-2 bladder tumor growth. This represents one of the most therapeutically promising preclinical findings for this species.
• Signaling pathways: Dendritic cell activation is mediated by increased phosphorylation of ERK1/2, JNK, and p38 MAPK, along with nuclear translocation of NF-kB p65 subunit, operating through TLR-4 and TLR-2 receptor pathways.

Secondary: Antiangiogenic Activity (Preclinical Evidence Only)

• Zebrafish developmental angiogenesis: L. nuda extract inhibited intersegmental vessel (ISV), caudal vein plexus (CVP), hyaloid vessel (HV), and subintestinal vessel (SIV) development in transgenic Tg(fli1:EGFP) zebrafish embryos, demonstrating potent antiangiogenic effects in vivo.
• HUVEC tube formation inhibition: The extract attenuated human umbilical vein endothelial cell (HUVEC) tube formation, migration, and invasion in vitro through inhibition of the MAPK/p38 signaling axis.
• Proangiogenic gene suppression: Treatment depleted expression of proangiogenic genes including growth factors (FGF, Ang2, VEGFa), receptors (Tie2, VEGFR2, endoglin), matrix metalloproteinases (MMP1, MMP2), and pro-inflammatory cytokines (IL-1alpha, IL-1beta, IL-6, TNF-alpha).
• Xenograft model: In zebrafish xenograft assays, L. nuda extract inhibited HuCCT1 cholangiocarcinoma cell-induced subintestinal vessel sprouting.

Secondary: Antioxidant Activity (Preclinical Evidence Only)

• Radical scavenging: Fruiting body extracts demonstrate notable antioxidant activity assessed by multiple methods: DPPH radical scavenging (EC50 0.98—1.18 mg/mL), beta-carotene bleaching inhibition (EC50 0.22—0.39 mg/mL), and reducing power (EC50 0.48—0.63 mg/mL).
• Flavonoid contribution: Total flavonoid content (19.02 mg catechin equivalents/g dry matter extract) contributes significantly to antioxidant capacity.

Emerging/Preclinical

• Antimicrobial activity: Extracts demonstrate antibacterial and antifungal activity against selected pathogens in vitro.
• Antiviral activity: Preliminary evidence for antiviral properties, though specific viral targets and mechanisms require further characterization.
• Metabolic protection: Extracts protected mice fed high-fat diets from changes associated with type II diabetes in preclinical models, suggesting potential metabolic support applications.
• Cytotoxic activity: Direct cytotoxic effects against selected cancer cell lines have been observed in vitro, independent of the immune-mediated mechanisms described above.
• Traditional use for skin conditions: Decoctions have been traditionally used for abscesses and wounds, suggesting wound-healing or antimicrobial properties that have not been formally validated.

Mechanism of Action

Primary Mechanisms

1. TLR-2/TLR-4-mediated dendritic cell activation: Water extract of L. nuda activates dendritic cells through dual engagement of toll-like receptors 2 and 4 (TLR-2 and TLR-4). This triggers intracellular signaling cascades involving phosphorylation of three major MAPK pathways (ERK1/2, JNK, p38) and nuclear translocation of NF-kB p65 subunit. The result is upregulation of MHC class II molecules and costimulatory molecules (CD40, CD80, CD86) on the dendritic cell surface, enhancing antigen presentation capacity. Functionally, this produces mature dendritic cells that drive allogenic T cell proliferation and IFN-gamma production, indicating a Th1-polarized immune response favorable for antitumor and antiviral immunity.

2. Vaccine adjuvant mechanism: The ability of WE-CN to enhance HER-2/neu DNA vaccine efficacy appears to operate through dendritic cell-mediated enhancement of antigen-specific T cell priming. By promoting dendritic cell maturation and Th1 cytokine production in the context of antigen delivery, WE-CN amplifies the adaptive immune response against the vaccine-encoded tumor antigen. This mechanism is conceptually similar to other immunostimulatory adjuvants that target innate immune pattern recognition receptors.

3. MAPK/p38-mediated antiangiogenic activity: L. nuda extract suppresses developmental and tumor-associated angiogenesis by inhibiting MAPK/p38 signaling in endothelial cells. This leads to downregulation of multiple proangiogenic factors (VEGF, FGF, angiopoietin-2), their receptors (VEGFR2, Tie2), and matrix metalloproteinases (MMP1, MMP2) required for endothelial cell migration and vessel formation. The broad suppression of proangiogenic signaling distinguishes this from single-target antiangiogenic agents.

Secondary Mechanisms

• Polysaccharide-mediated immune activation: LNP-1 and LNP-2 polysaccharides (MW 11,703 and 13,369 Da) are heteropolysaccharides containing mannose, glucose, galactose, xylose, arabinose, and fucose. These likely contribute to the immunomodulatory activity of water extracts through pattern recognition receptor interactions, though their individual contributions to dendritic cell activation have not been fully dissected.
• Phenolic compound antioxidant activity: Gallic acid, protocatechuic acid, and flavonoid compounds scavenge free radicals through hydrogen atom transfer and single electron transfer mechanisms, contributing to the overall antioxidant capacity of extracts.
• Thermolabile toxin mechanism: Raw L. nuda contains compounds (possibly trehalose derivatives or related molecules) that cause gastrointestinal distress. These are inactivated by thorough cooking, establishing a clear requirement for thermal processing before consumption.

Clinical Evidence Summary

No human clinical trials have been published for wood blewit or its extracts as of this writing. All evidence for bioactive properties derives from in vitro cell culture studies, zebrafish developmental models, and mouse tumor models.

Key Preclinical Studies

Evidence Limitations

• No human clinical trials: All evidence is preclinical. The most promising finding — DNA vaccine adjuvant activity — has only been demonstrated in a mouse tumor model and requires substantial further development before clinical translation.
• Extract standardization challenges: Different studies use water, ethanolic, or methanolic extracts with different bioactive profiles, making cross-study comparison difficult.
• Limited polysaccharide characterization: While LNP-1 and LNP-2 have been structurally characterized, their specific contribution to the immunomodulatory effects observed in the dendritic cell and vaccine adjuvant studies has not been established.
• Antiangiogenic dose-response: The antiangiogenic effects demonstrated in zebrafish embryos and HUVECs require validation in mammalian tumor angiogenesis models with therapeutically relevant dose regimens.
• Wild-harvested variability: The bioactive profile varies with collection habitat, season, and growing conditions. Commercial cultivation on composted substrates is possible but not widespread, limiting material standardization.
• Cooking requirement complicates medicinal food use: The necessity of thorough cooking to inactivate thermolabile toxins may also degrade heat-sensitive bioactive compounds, potentially reducing the therapeutic value of culinary preparations compared to controlled extraction.

Safety Profile

General Assessment

Wood blewit has been consumed as a cooked edible mushroom across Europe for centuries, with a generally good safety record when properly prepared. The critical safety requirement is thorough cooking — raw or undercooked specimens cause gastrointestinal distress. Some individuals experience allergic reactions even to well-cooked specimens.

Contraindications

• Raw consumption: Strictly contraindicated. Raw wood blewit contains thermolabile compounds that cause nausea, vomiting, and diarrhea. All specimens must be thoroughly cooked before consumption.
• Mushroom allergy: Allergic reactions have been reported even after cooking in susceptible individuals. Persons with known mushroom allergies should avoid consumption.
• Misidentification risk: Purple-lilac Cortinarius species (e.g., C. archeri in Australia) and certain Clitocybe species can be confused with wood blewit. Cortinarius species can be highly toxic (nephrotoxic). Only experienced foragers should collect wild blewits.
• Pregnancy and lactation: No safety data for concentrated extracts. Cooked culinary consumption is presumed safe based on traditional European use.

Drug Interactions

No drug interactions have been documented. Theoretical interactions based on preclinical activity:

• Immunosuppressants: The dendritic cell-activating and Th1-polarizing activity of wood blewit extracts could theoretically counteract immunosuppressive therapy. Clinical significance at dietary doses is unknown.
• Antiangiogenic therapies: Theoretical additive effect with pharmaceutical antiangiogenic agents (bevacizumab, sunitinib) based on preclinical MAPK/p38 pathway suppression. Clinical relevance is highly uncertain.
• Anticoagulants: No specific interaction data, but the broad anti-inflammatory cytokine modulation warrants general caution in patients on anticoagulant therapy.

Side Effects (at Culinary Doses, Properly Cooked)

• Rare: Allergic reactions in sensitized individuals, manifesting as gastrointestinal symptoms or dermatological reactions.
• From raw/undercooked consumption: Nausea, vomiting, diarrhea, and abdominal cramps. Symptoms are self-limiting and resolve without treatment.

Toxicology

• Thermolabile compounds: Raw wood blewit contains compounds (possibly trehalose derivatives or cyanohydrins) that are inactivated by cooking. The specific identity of these thermolabile toxins has not been fully characterized.
• No accumulative toxicity has been reported from repeated consumption of properly cooked specimens.
• Cultivation substrate safety: Commercially cultivated wood blewits grown on composted substrates are subject to food safety regulations in EU markets.

Clinical Dosage

Culinary Use (Food)

• Fresh fruiting body (cooked): No established medicinal dose. Consumed as a food in European cuisine, typically 50—150 g fresh weight per serving. Must be thoroughly cooked (minimum 15—20 minutes at cooking temperature).
• Dried fruiting body: Approximately 5—15 g dried weight, reconstituted and cooked.
• Common preparations: Sauteed in butter or oil, added to stews, cream sauces, risottos, or pasta dishes. Drying and subsequent reconstitution is a traditional preservation method.

Water Extracts (Preclinical Only)

• No established human clinical dose. Preclinical studies have used:
  • Water extract of C. nuda (WE-CN) in vitro on dendritic cells at various concentrations
  • Mouse in vivo doses for vaccine adjuvant experiments
• These doses cannot be directly translated to human recommendations without pharmacokinetic and clinical dose-finding studies.

Form Selection Guidance

As no clinical evidence supports specific dosing for medicinal use, wood blewit is best regarded as a nutritious culinary mushroom with promising preclinical immunomodulatory research. The requirement for thorough cooking is non-negotiable from a safety standpoint. Hot-water extraction (as occurs during cooking, making soups, or preparing decoctions) would be expected to extract water-soluble polysaccharides and immunomodulatory compounds effectively, though the precise relationship between culinary preparation and bioactive compound availability has not been systematically characterized.

Traditional Preparations

• Infusion: Traditional use for preventing beriberi (vitamin B1 deficiency), consistent with the vitamin B1 content of the fruiting body.
• Decoction: Traditional topical use for abscesses and wounds. Antimicrobial activity of extracts provides a partial rationale for this traditional application.

Sources

• Chen JT, Hsieh RH. Clitocybe nuda Activates Dendritic Cells and Acts as a DNA Vaccine Adjuvant. Evid Based Complement Alternat Med. 2013;2013:761454
• Chu YC, Chang CL, Chiou WF, Peng WH, Chen YF. Antiangiogenic potential of Lepista nuda extract suppressing MAPK/p38 signaling-mediated developmental angiogenesis in zebrafish and HUVECs. Biomed Pharmacother. 2023;159:114240
• Vaz JA, Barros L, Martins A, Santos-Buelga C, Vasconcelos MH, Ferreira ICFR. Chemical characterization and antioxidant properties of Lepista nuda fruiting bodies and mycelia obtained by in vitro culture: Effects of collection habitat and culture media. Food Res Int. 2013;51(2):496-502
• Heleno SA, Barros L, Sousa MJ, Martins A, Ferreira ICFR. Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity. Food Chem. 2010;119(4):1443-1450
• Chen Y, Li M, Wang H, Zhang Y. Extraction, purification and properties of water-soluble polysaccharides from mushroom Lepista nuda. Int J Biol Macromol. 2019;128:858-869
• Ouali Z, Sbai A, Ferraro V, Ferrante C, Ferro S, Ferrante D. Antioxidant Properties, Bioactive Compounds Contents, and Chemical Characterization of Two Wild Edible Mushroom Species from Morocco: Paralepista flaccida (Sowerby) Vizzini and Lepista nuda (Bull.) Cooke. Molecules. 2023;28(4):1627
• De A, Ghosh S, Chakraborty N. A review on Blewit mushrooms (Lepista sp.) transition from farm to pharm. J Food Process Preserv. 2022;46(12):e17028
• Barros L, Baptista P, Correia DM, Casal S, Oliveira B, Ferreira ICFR. Fatty acid and sugar compositions, and nutritional value of five wild edible mushrooms from Northeast Portugal. Food Chem. 2007;105(1):140-145
• Ma G, Yang W, Zhao L, Pei F, Fang D, Hu Q. A critical review on the health promoting effects of mushrooms nutraceuticals. Food Sci Hum Wellness. 2018;7(2):125-133
• Roupas P, Keogh J, Noakes M, Margetts C, Taylor P. The role of edible mushrooms in health: Evaluation of the evidence. J Funct Foods. 2012;4(4):687-709
• Ferreira ICFR, Vaz JA, Vasconcelos MH, Martins A. Compounds from wild mushrooms with antitumor potential. Anticancer Agents Med Chem. 2010;10(5):424-436

Connections

• Dendritic cell-activating mushrooms: The dendritic cell maturation and vaccine adjuvant activity of wood blewit extract represents a distinctive and therapeutically interesting mechanism among medicinal mushrooms. While many medicinal mushrooms activate innate immunity via macrophage stimulation (e.g., Turkey Tail, Maitake, Shiitake), the specific demonstration of DNA vaccine adjuvant activity with antitumor efficacy sets wood blewit apart in preclinical research. The TLR-2/TLR-4 dual pathway engagement is shared with several mushroom polysaccharides but the functional vaccine adjuvant outcome has been most explicitly demonstrated for this species.
• Antiangiogenic medicinal fungi: The potent antiangiogenic activity of L. nuda extract through MAPK/p38 suppression is a relatively unusual finding among edible mushrooms. While some mushroom-derived compounds (e.g., triterpenoids from Reishi) have demonstrated antiangiogenic properties, the comprehensive suppression of proangiogenic gene expression shown for wood blewit extract is notable.
• European wild edible tradition: Wood blewit represents the European tradition of wild-foraged culinary-medicinal mushrooms, complementing the predominantly East Asian medicinal mushroom canon that dominates this reference. Its long history in French, Spanish, and Portuguese cuisine provides a cultural context distinct from the TCM and kampo frameworks that inform most medicinal mushroom research.
• Cooking requirement as a safety model: The strict requirement for cooking wood blewit before consumption provides a useful case study in mushroom safety. The thermolabile toxins in raw blewit highlight that “edible” and “safe to eat raw” are distinct categories for mushrooms, relevant to discussions about consuming any medicinal mushroom as a food.
• Synergy potential: The dendritic cell-activating and Th1-polarizing properties of wood blewit could theoretically complement the innate immune activation provided by beta-glucan-rich mushrooms such as Turkey Tail (PSK/PSP) or Shiitake (lentinan), providing coordinated innate and adaptive immune stimulation. This combination concept remains untested but is mechanistically plausible.